Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II).

Trial Profile

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II).

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2018

At a glance

  • Drugs Ranibizumab (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Apr 2012 Actual patient number is 6 according to ClinicalTrials.gov.
    • 02 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top